Implementing LGBTQ+ inclusive language in patient care and clinical trials for dermatology could improve data accuracy, ...

Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with ...

Medicare Part B drug negotiations in 2028 pose challenges for providers, requiring new payment systems and strategies to ...

With potential lung cancer nodules sometimes slipping through the cracks, educating stakeholders about artificial ...

Innovative therapies for ovarian cancer, including engineered T cells and antibody-drug conjugates, show promise in improving ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in ...

Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in ...

In this final part of a recent interview with Jonathan Strober, MD, UCSF Benioff Children's Hospital and phase 2/3 ...

Panelists discuss how surgical approaches for bronchiectasis have evolved from open thoracotomy to minimally invasive ...

Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.

Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.